Marie Thrysoe Kruse

Title: Innovator Spotlight: Marie Thrysoe Kruse

Introduction

Marie Thrysoe Kruse, based in Vaerloese, Denmark, is an accomplished inventor with a significant contribution to the field of biotechnology. With a total of three patents to her name, her work primarily focuses on endoglucanase variants, which play a crucial role in various industrial applications, particularly in biofuel production and cellulosic processes.

Latest Patents

Kruse's latest patents include the innovative designs for GH9 endoglucanase variants and the polynucleotides encoding them. These inventions encompass methods for obtaining endoglucanase variants and detail the nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides. This research provides valuable advancements in the field by enhancing the efficiency of enzyme applications.

Career Highlights

Throughout her career, Kruse has made a notable impact in the biotechnology industry while working for prestigious companies such as Novozymes A/S and Henkel AG & Company, KGaA. Her experience at these organizations has allowed her to collaborate on various projects and develop innovative solutions for complex challenges in bioengineering.

Collaborations

Marie has collaborated with several prominent figures in her field, including Lars Anderson and Jens Erik Nielsen. Their partnership has fostered a creative environment that encourages the exploration of new ideas and techniques, resulting in cutting-edge biotechnological innovations.

Conclusion

Marie Thrysoe Kruse stands out as a distinguished inventor and leader in the biotechnology industry. Her contributions through her patents and collaboration with industry professionals demonstrate her commitment to advancing scientific research and innovation. With her expertise, the future of biotechnology looks promising, paving the way for further developments in enzyme technology and its applications.